SLC7A2 and hepatocellular carcinoma: Recent studies have shown that lower SLC7A2 expression is associated with worse prognosis of ovarian cancer and hepatocellular carcinoma [6, 7], and SLC7A2 deficiency in inflammatory bowel tissues increases the risk of inflammation-associated colon tumorigenesis [8].